Skip to main content
SpringerLink
Log in

Reduced bisphosphonate schedule may decrease jaw osteonecrosis risk

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Zappasodi P, Corso A, Varettoni M, Klersy C, Pica G, Mangiacavalli S, Lazzarino M.Bisphosphonates and osteonecrosis of the jaw: advantages of a new schedule. Blood 108: 1025a, No. 11, Part 1, Nov 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reduced bisphosphonate schedule may decrease jaw osteonecrosis risk. React. Wkly. 1135, 1 (2007). https://doi.org/10.2165/00128415-200711350-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711350-00001

Keywords

Search

Navigation